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Summary 1-Naphthol was selectively toxic to human colorectal tumours compared to corresponding normal
colonic tissue removed at surgery and maintained in short-term organ culture. Nineteen of 24 tumours studied
have shown a significant differential response. Three human colonic adenocarcinoma xenografts, in the short-
term organ culture system, displayed the same response to l-naphthol as primary tumours removed at
surgery. I-Naphthol, 1,2- and 1,4-naphthoquinone were also toxic to two human colonic adenocarcinoma cell
lines, LoVo and COLO 206. The selective toxicity of l-naphthol is mediated in part through an accumulation
of l-naphthol in the tumour tissue due to impaired conjugation by the tumour. The higher concentrations of
1-naphthol may then exert their toxicity either directly or by formation of naphthoquinones. Some indirect
evidence was obtained for the possible involvement of 1,2- or 1,4-naphthoquinone in the cytotoxicity of 1-
naphthol. Our studies suggest that further studies are warranted of the possible use of l-naphthol or related
compounds as antitumour agents.
Colorectal cancer, in common with the majority of
other solid tumours, has remained unresponsive, as
judged by long-term survival, to current chemo-
therapeutic agents (Carter et al., 1981). The reason
for this failure is primarily due to the low propor-
tion of dividing cells in carcinomas of the colon,
rectum, breast and lung. In general, anticancer
drugs such as the alkylating agents or anti-
metabolites are most effective against tumours
with a high proportion of dividing cells such as the
leukaemias and lymphomas (Carter et al., 1981).
The effectiveness of this type of drug is limited by
host toxicity to the rapidly dividing normal tissues
of the bone marrow and gut epithelium.
A major problem in colorectal cancer is that
often the tumour cells have a slower growth rate
than cells from the normal epithelium. Cell growth
in normal colon, however, is balanced by equal cell
loss by exfoliation, whereas the rate of cell loss is
reduced in tumours (Weisburger et al., 1975). Only
5-fluorouracil and the chloroethyl-nitrosoureas have
shown limited utility in advanced colorectal disease
achieving an objective response rate of 10-20% but
without any significant effect on long-term survival
(Falkson et al., 1976; Moertel, 1978).
In this study, the effects of l-naphthol on a
variety of different model colonic tumour systems
were investigated. The rationale for this arose from
our previous studies on routes of conjugation in
normal and tumour tissue from human lung
(Cohen et al., 1981) and more recently, colon
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(Cohen et al., 1983a; Gibby & Cohen, 1984). In
these studies, 1-naphthol was used as a model
phenolic substrate to study both glucuronidation
and sulphation. We found that squamous cell
carcinomas of the lung formed, almost exclusively,
the glucuronic acid conjugate whilst short-term
organ cultures of normal peripheral lung from the
same patients formed the sulphate ester conjugate
(Cohen et al., 1981). A similar but not as dramatic
difference was found between colorectal tumours
and corresponding normal tissue (Cohen et al.,
1983a; Gibby & Cohen, 1984). The process of
glucuronic acid conjugation requires UDP-
glucuronic acid as an essential co-factor. Con-
sequently, by supplying a substrate such as 1-
naphthol, the tumour tissue could be selectively
depleted of UTP and thus disturb nucleic acid
biosynthesis. Initially we wished to use 1-naphthol
in combination with 3-deazauridine, which blocks
CTP synthetase (McPartland et al., 1974), in order
to totally inhibit synthesis of cytidine nucleotides in
an analogous manner to the combination of D-
galactosamine and 3-deazauridine used in the
treatment of hepatomas (Lui et al., 1976). In a
preliminary study we noted that this combination
did not have the desired effect, however 1-naphthol
showed a marked selective toxicity to short-term
organ cultures of colonic tumour tissue compared
to normal colonic tissue from the same patients
(Cohen et al., 1983b).
This study was therefore designed to confirm,
extend and investigate the possible mechanism of
the selective toxicity of 1-naphthol to short-term
organ cultures of human colorectal tumour tissue
compared to normal colonic tissue.
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Materials and methods
Organ culture
Human primary colorectal tumours and ap-
propriate, macroscopically, normal tissue removed
at surgery were transported to the laboratory, on
ice, in Leibovitz L-15 medium (Gibco Biocult,
Paisley, Scotland) containing 100iumlI penicillin,
100pgml-1 streptomycin, 50 ugml1 gentamycin
and 50pgml- I fungizone.
The tissues were processed immediately, the
normal mucosa was carefully excised from the
muscle and connective tissue layers and
macroscopically necrotic areas removed from the
tumour. Both tissues were cut into 2mm explants
using a razor blade. Two strips of 3mm gel foam
(Upjohn, Kalamazoo, Missouri), previously soaked
in L-15 medium; were placed on scratched surfaces
at opposite ends of each compartment of a
6 x 35mm multi-well dish (Sterilin Ltd, London,
UK).
Two explants were then placed on each piece of
gel foam. One ml of CMRL-1066 medium (Gibco
Biocult) supplemented with 1.25% bovine albumin
crystallised (Miles Biochemicals, Slough, UK),
1 mM L-glutamine, 1% D-glucose, 1 pgml -
hydrocortisone, 100iumlP1 penicillin, 100jgml1
streptomycin, 50jgmlP gentamycin and buffered
with 20mM Tricine (Gibco Biocult), was added to
each well. The plates were placed in a perspex
culture chamber (Bellco Glass Inc, New Jersey,
USA) and gassed with 95% 02:5% CO2. The
chamber was then rocked at 10 cyclesmin-m on a
low profile rocker (Bellco Glass Inc.) in an
incubator at 37°C.
The system was essentially the same as that
described by Autrup et al. (1978) and was designed
such that the tissue was submerged 50% of the
time. Using this system, normal human colon can
be cultured for periods of up to 20 days (Autrup et
al., 1978). In the present studies, the cultures were
allowed to equilibrate for 24h prior to their
treatment for a further 24h. The rate of in-
corporation of [3H]-leucine into protein remained
constant throughout the 24h treatment period in
both normal and tumourous tissue.
Routine histological examination was performed
on fresh and cultured specimens and tissue integrity
was maintained throughout the 48h incubation
period. None of the patients had received prior
chemotherapy and the series consisted of a spectrum
of well to poorly differentiated carcinomas of the
colon, rectum and caecum.
Cell cultures
Two human colonic adenocarcinoma cell lines,
LoVo (Drewinko et al., 1976) and COLO 206
(Semple et al., 1978) were used. LoVo cells were
grown as monolayers in 90mm petri-dishes
(Sterilin) in Hams F-12 medium (Flow
Laboratories, Irvine, Scotland) supplemented with
10% foetal bovine serum (Flow Labs), 1 mM L-
glutamine, penicillin and streptomycin as before.
COLO 206 cells were grown in suspension in
25sq. cm flasks (Sterilin) in RPMI 1640 medium
(Gibco Biocult) containing 10% foetal bovine
serum and penicillin/streptomycin as before. All
cultures were maintained in a humidified 5% CO2
atmosphere in air at 37°C and routinely subcultured
each week.
Xenografts
Three human colonic adenocarcinoma xenografts
were used, designated PXN 1, P 76 and LoVo.
PXN 1 and P 76 were established from explants of
primary tumours, LoVo xenografts were established
from a subcutaneous inoculum of a cell suspension.
All three xenografts showed acinar formations, the
most extensive being found in the LoVo xenografts.
PXN 1 and P 76 were encapsulated by murine
connective tissue and both contained varying
amounts of stroma with pockets of lymphoid
infiltrate. LoVo xenografts which were not
encapsulated, were well vascularized and showed
little stroma or lymphoid infiltrate. All xenografts
were harvested for culture when 1 cm in
diameter.
Treatment ofcultures with J-naphthol and
naphthoquinones and assessment ofcytotoxicity
A range of concentrations of 1-naphthol or
naphthoquinones were added to culture media in
DMSO, the final concentration of which was 1% in
both control and test cultures. Human colonic
tumour cells or organ cultures of human colonic
tumour and normal tissue were incubated with
these compounds for 24h prior to assessment of
cytotoxicity. The toxicity to organ cultures and cell
lines was assessed by measuring an inhibition in
protein synthesis. In addition clonogenic survival
and dye exclusion were used as additional assays of
toxicity to cell lines.
When cytotoxic effects were assessed by
measuring an inhibition of protein synthesis using a
pulse of tritiated leucine, the radioactive precursor
L-[4, 53H]-leucine (specific activity 60Cimmol-1,
Amersham International, UK) was added to the
cultures, 2h before the end of the incubation
period. In short-term organ cultures 2pCi (100p1)
was added to each compartment. At the end of the
pulse period, the medium was decanted and the
tissue blotted on 0.9% NaCl solution-soaked filter
paper before unbound radioactivity was extracted
for 10min in ice-cold 10% TCA. After extraction,SELECTIVE TOXICITY OF 1-NAPHTHOL 855
the tissue was blotted again and placed in a mini-
vial containing 100p1 of 1 M NaOH and solubilised
overnight at 37°C. An aliquot of the solubilised
sample was removed for protein estimation (Lowry
et al., 1951) and the remainder acidified and
counted in a Rackbeta 1216 scintillation counter
(L.K.B. Sweden) in Aquasol (New England Nuclear
Ltd, Edinburgh, Scotland). The results were
calculated as dpmmg-1 protein and expressed as
percentage change of control cultures for
comparative purposes.
LoVo cells were seeded into 96-well, flatbottomed
microtitre plates (Sterilin) at a concentration of
105cellsml-1, 200 1 being added to each well.
Cytotoxicity was assessed by pulsing with 1 pCi
(50p1) [3H]-leucine per well. The remainder of the
procedure was essentially the same as for organ
culture except that the cells remaining attached in
each well were extracted in situ and the dpm
incorporated into these cells expressed as a
percentage of controls. A marked decrease in cell
number was observed in cell cultures treated with
higher concentrations of 1-naphthol. Thus this
measure of cytotoxicity is due to both inhibition of
protein synthesis in those cells remaining attached
to the plate and to a decrease in cell number.
COLO 206 cells were seeded into 10x 160mm
tissue culture tubes (Sterilin) at a concentration of
5 x105 cells per tube and pulsed with 2pCi [3H]-
leucine. The remainder of the procedure was again
the same as described for organ culture except that
centrifugation was required between each step.
Clonogenic survival was assessed by exposing log
phase monolayers of LoVo cells to various
concentrations of 1-naphthol or 1,4-naphtho-
quinone for 24h. Attached and detached cells were
harvested by trypsinisation and centrifugation of
culture medium and plated onto 5cm petri-dishes in
Hams F-12. medium containing 10% FCS at
appropriate cell concentrations such that -100
colonies were present after 10 days. Colonies were
stained with Leishman's stain (Searle Diagnostic,
Bucks.) and the cloning efficiency of the cells plated
from control and treated cell cultures assessed. The
average cloning efficiency of control cells over 6
experiments was 30+6%. After 24h exposure to
the higher concentrations of 1-naphthol (500-
1,000pM), a smaller number of cells than those
originally treated were recovered following
trypsinisation of the cells remaining attached to the
plates and combining them with the detached cells
in the medium. The results of the clonogenic assay
are expressed as a percentage of control assuming
that the cells lost during the treatment period
would have been incapable of forming colonies in
this assay.
Trypan blue exclusion was assessed in LoVo cells,
after trypsinisation, and in COLO 206 cells after
centrifugation, by resuspending the cells in 0.1%
trypan blue in 0.9% NaCl solution. Viability was
assessed by counting the percentage of the cells
excluding trypan blue. The results are expressed as
a percentage of control, scoring the cells lost from
the cultures treated with the higher concentrations
of 1-naphthol as non-viable.
Metabolism of[1- 14C]-1-naphthol
The metabolism of [1- 14C]-l-naphthol (Amersham
InternationalLtd.,Bucks,UK.sp.act. 19.4Cimmol 1)
in short-term organ cultures and human colonic
tumour cell lines was determined as previously
described (Gibby & Cohen, 1984).
Chemicals
All chemicals used were purchased from Sigma
Chemical Co (London, England) except for 1,2- or
1,4-naphthoquinone which were obtained from
Fluka, Switzerland.
Results
Assessment ofcytotoxicity ofJ-naphthol by
inhibition ofprotein synthesis, clonogenic survival
and dye exclusion
The cytotoxicity of 1-naphthol to LoVo cells
(Figure la) and COLO 206 cells (Figure lb) was
assessed by inhibition of protein synthesis,
clonogenic survival (LoVo cells only) and trypan
blue exclusion. In both cell lines, a reasonable
correlation was observed between these measures of
cytotoxicity (Figure la and b). A striking
observation in the cell cultures treated with high
concentrations of 1-naphthol (0.5-1 mM) was cell
loss, presumably due to cell lysis and an inhibition
of cell division, which occurred during the 24h
exposure period. For example following treatment
of LoVo cells with 1 mM l-naphthol for 24h it was
only possible to recover 33% of the number of cells
present in control cultures at that time. The
assessment of toxicity using each of these assays
varied depending on whether this cell loss was
taken into account or not. For example, the ID50
values for clonogenic survival vary from
327+57pM to 603+57pM depending on whether
the results are corrected for cell loss during
exposure time or solely expressed as the cloning
efficiency of the cells remaining in the culture at the
end of the treatment period.
As cytotoxicity assessed by protein synthesis
inhibition was in reasonable agreement with that
obtained by clonogenic survival and trypan blue
exclusion (Figure 1). It was decided to use this
assay as a measure of toxicity in the short-term856 G.D. WILSON et al.
organ cultures of the primary colorectal tumours
and appropriate normal tissue, taken at surgery.
This was also necessitated because of the inability
to measure the toxicity to normal colon by a
clonogenic assay.
The effects ofJ-naphthol on normal and tumour
tissuefrom the same patients and human tumour
xenografts
The effects of 1-naphthol were studied on a series
of 24 human colorectal tumours and corresponding
normal tissue taken at surgery and maintained in
short-term organ culture (Figure 2). As we had
previously shown in a preliminary report (Cohen et
al., 1983b) in 18/24 patients, protein synthesis was
inhibited in short-term organ cultures of colonic
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Figure 1 Assessment of cytotoxicity of l-naphthol in
human colonic adenocarcinoma cell lines (a) LoVo; (b)
COLO 206, by various methods. Protein synthesis (0)
is expressed as percentage change compared to control
cultures, and trypan blue exclusion (0) as a
percentage viability compared to control cultures.
Each point is the mean of 4 replicates from 2 different
24h incubations with l-naphthol. Clonogenicity (x) is
expressed as a percentage of the cloning efficiency of
control cultures. Each point is the mean of 3 replicates
in each of 3 separate experiments. All data has been
corrected for any cell loss observed during the
treatment.
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Figure 2 Selective toxicity of l-naphthol to short-
term organ cultures of human colorectal tumours
compared to normal colorectal tissue from the same
patient. Each specimen was tested with 2-4
concentrations of 1-naphthol with at least 4 replicate
cultures at each concentration. Cumulative data for
the tumour (0) and normal (0) specimens from
eighteen patients as well as the mean for three
different human colonic adenocarcinoma xenografts
(V) are shown. Toxicity was assessed by protein
synthesis inhibition and expressed as percentage of
control cultures without l-naphthol. All incubations
with l-naphthol were of 24h duration. Significance
was tested using 2-two tailed independent t-test
*(P<0.002). **(P<0.005), ***(P<0.001).
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tumour tissue by lower concentrations of 1-
naphthol than in the corresponding normal colonic
tissue from the same patients (Figure 2). Five
patients were not shown, who did not exhibit a
differential effect and one other patient was omitted
as only a single dose of 1-naphthol was studied.
The half maximal inhibition of protein synthesis
wasreached at aconcentration of0.76mM 1-naphthol
in the tumour tissue but was not evident until
2.1 mM in normal tissue (Figure 2). In this model
system, significant inhibition of protein synthesis
in colonic tumour tissue was observed between 0.5
and 1 mM 1-naphthol whereas the normal colon was
unaffected at these concentrations (Figure 2).
Human colonic tumour xenografts showed a very
similar response to short-term cultures of colonic
tumour tissue (Figure 2).
Metabolism of J-naphthol in normal and tumour
tissues in relation to toxicity
A possible mechanism of the selective toxicity of 1-
naphthol may be the preferential depletion of
uridine nucleotides in the tumour tissue, resulting
from more extensive utilisation of UDP-glucuronic
acid due to higher levels of glucuronic acid
conjugation in the tumour tissue compared to the
normal tissue (Cohen et al., 1981). As our previous
studies (Cohen et al., 1983a; Gibby & Cohen, 1984)
with colonic tissue had been carried out at non-
toxic concentrations of 1-naphthol (20 and 100uM)
it was necessary to see if such metabolic differences
also occurred at toxic concentrations of 1-naphthol
(1 mM). In order to confirm and extend our
previous observations, the metabolism of [1-14C]-
1-naphthol was therefore studied at 20yM and
1 mM (Table I and Figure 3). At low con-
centrations of 1-naphthol (20MuM), normal colon
formed significantly more 1-naphthyl sulphate than
1-naphthyl-,B-D-glucuronide whereas in the tumour
tissue, a marked decrease in overall metabolism and
in particular in sulphate ester conjugation was
observed (Table 1 and Figure 3). The levels of the
metabolites present in the normal and tumour
tissue are essentially in agreement with our previous
results where the metabolites in the medium were
examined (Gibby & Cohen, 1984). A different
pattern of metabolism was observed at high con-
centrations of 1-naphthol (1 mM) when more
glucuronic acid than sulphate ester conjugates were
observed in both normal and tumour tissues (Table
I). At the high concentration of 1-naphthol a
marked decrease in overall metabolism in the
tumour tissue was also observed (Table I and
Figure 3). This decrease in overall metabolism
suggested that more unmetabolised 1-naphthol may
be present in the tumour tissue which may then
exert its toxicity by some other mechanism.
Table I Phase II metabolites of [1- 4C]-1-naphthol (20 and 1,000PM)
present in tissue explants from short-term organ cultures of human colonic
tumour and normal tissue.
20pM J-naphthol ImM J-naphthol
l-naphthol conjugates?found in:
Colon Tumour Colon Tumour
Patient I-NS J-NG I-NS l-NG I-NS l-NG I-NS J-NG
I 61.3 16.2 27.0 11.5 6.9 26.6 1.7 2.8
II 71.1 10.1 2.6 3.3 2.9 7.4 0.1 0.2
III 49.7 26.9 22.5 24.3 4.0 33.6 1.7 10.0
IV 36.8 6.2 5.7 56.2 5.7 29.8 1.0 14.6
V 43.1 7.4 3.3 4.9 6.3 47.2 3.5 12.1
VI 20.7 29.0 2.7 27.5 1.9 22.2 0.8 5.2
VII NDb ND ND ND 7.5 60.4 2.8 19.7
1-NS 1-naphthyl sulphate; 1-NG 1-naphthyl P-D-glucuronide. aExpressed as a percentage of the radioactivity present mg-' tissues, bND
=not determined.
Short-term organ cultures of macroscopically normal human colonic mucosa
and tumour tissue were cultured for 24h at 37°. The medium was then
replaced by fresh medium containing [1-14C]-1-naphthol (5.6-19.2Cimol-1)
and incubated for a further 24h. The tissue, in lots of 4 pieces from a single
incubation, was then homogenised in water and the protein precipitated prior
to TLC of the supernatant fraction. Between 50 and 77% of the total
radioactivity was recovered in the medium (1 ml) at the end of the incubations.858 G.D. WILSON et al.
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Figure 3 Time course of appearance of Phase II metabolites of l-naphthol (1 mM) in the culture medium
from short-term organ cultures of human colonic tumour and normal tissue. Short-term organ cultures of
normal human colonic nucosa (0) and colonic tumour tissue (0) from the same patients were incubated
from 4-48 h as described in Materials and methods. The concentrations of (a) -naphthyl-fi-D-glucuronide and
(b) l-naphthyl sulphate present in the culture medium were determined following separation of the
metabolites in the incubation mixture by TLC as described in Materials and methods. The results are
expressed as mean+ s.e. ofvalues from 3-6 patients.
In order to test this hypothesis, we measured the
concentrations of unmetabolised 1-naphthol present
in the tissue from short-term organ cultures of
normal human colon and colonic tumour tissue
at various times from 4-48 h. At each time point,
the toxicity was also measured by inhibition of
protein synthesis. Over the time period studied, a
marked increase in the selective toxicity of 1-
naphthol to the tumour tissue was observed (Figure
4a). This was accompanied by an accumulation of
unmetabolised 1-naphthol in the tumour tissue and
a decrease in unmetabolised 1-naphthol in the
explants of normal colon after 4h of incubation
(Figure 4b). At all times studied, the tumour tissue
contained more unmetabolised 1-naphthol than the
normal tissue. The changing concentrations of 1-
naphthol in the tumour and normal tissue were also
reflected in the metabolites of 1-naphthol found in
the culture medium during the same incubations
(Figure 3). The media from the organ cultures of
normal colon showed a marked increase in the
concentrations of both 1-naphthyl-,B-D-glucuronide
and l-naphthyl sulphate but only a very small
increase in these metabolites was observed in the
tumour tissue (Figure 3).
Metabolism of J-naphthol in human colonic tumour
cell lines in relation to toxicity
The metabolism and toxicity of 1-naphthol (20-
1,000pM) by the human colonic tumour cell line
COLO 206 were studied. More l-naphthyl-f-D-
glucuronide than l-naphthyl sulphate was formed
at all concentrations (Figure 5). Maximal formation
of the glucuronic acid conjugate was observed at a
concentration of l-naphthol of 100pM which was
only marginally toxic to the cells (compare Figure 5
and lb). Although the toxicity of l-naphthol to
LoVo cells was similar to COLO cells (ID50 320
and 280yM respectively for inhibition of protein
synthesis) the amount of glucuronic acid conjugates
formed was far smaller (Table II).
The results obtained with both the cell lines and
the organ culture did not support a mechanism of
selective toxicity of l-naphthol, which was depen-
dent on uridine nucleotide depletion (see Discussion).
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Figure 4 Time course of l-naphthol (1 mM) toxicity to short-term organ cultures of human colonic tumour
and normal tissue (a), and 1-naphthol accumulation within these tissues (b). Short-term organ cultures of
normal colonic mucosa (0) and colonic tumour tissue (0) from the same patients were incubated for 4-48h
with l-naphthol (1 mM) as described in the legend to Figure 2.
(a) Cytotoxicity was assessed by measuring inhibition of protein synthesis following a 2h pulse with [3H]-
leucine.
(b) Replicate cultures were incubated with [1- 14C]-l-naphthol (1 mM) and after identical time periods the
amount of unmetabolised l-naphthol present in the tissues was assessed by TLC, following homogenisation of
the tissue in water and precipitation ofprotein.
The results are presented as the mean+s.e. of values obtained from tissue of 3-6 patients (34
determinations on each).
0.2 0.4 0.6 0.8 1.0
available for exerting its toxicity by another
100 mechanism. Recently we have shown that 1-
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Figure 5 Effects of the concentration of l-naphthol
on its Phase II metabolism in a human colonic tumour
cell line. [1- 4C]-I-Naphthol (20-1,000pM) was
incubated for 24h with COLO 206 cells (0.81 x 106
cellsml-1). The glucuronic acid and sulphate ester
conjugates in the culture medium were separated by
TLC and quantified as described in Materials and
methods.
The higher concentrations of unmetabolished 1-
naphthol in the tumour compared to the normal
tissue suggested that more l-naphthol may be
Possible involvement ofnaphthoquinones in
J-naphthol toxicity
Likely toxic metabolites from 1-naphthol are either
or both 1,2-or l,4-naphthoquinone. Both are
known cytotoxic agents and have been used as
antifungal and putative antitumour agents in
various forms (Driscoll et al., 1974). The effect of
the naphthoquinones were studied in both short-
term organ cultures of colorectal tissues (Figure 6a)
and LoVo cells (Figure 6b). It was evident that, in
both these model systems, the quinones showed
greater toxicity than l-naphthol as would be
expected if they were active metabolites. The
toxicity of l,4-naphthoquinone to LoVo cells was
very similar when assessed either by clonogenic
survival (IDs=5024+2/pM) or by protein synthesis
inhibition (ID50 =31±+2yM) (Figure 6). In LoVo
cells, 1,2-naphthoquinone, compared to l-naphthol
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Table II Comparison of the ID50 value for the inhibition of protein synthesis by 1-
naphthol in two human tumour cell lines and their capacity for Phase II metabolism
of 1-naphthol
nmoles nmoles
1-naphthyl-fi-D-glucuronide 1-naphthyl sulphate
ID50 J-Naphthol formed mg-' formed mg-1
Cell line (PM) (jIM) protein 24h 1 protein 24h-
COLO 206 280 50 184.5+ 5.6 3.4+0.6
100 368.7+ 4.1 5.6+0.5
250 290.5+ 12.5 4.0+0.5
500 79.5+16.8 1.7+0.4
750 53.3+ 4.2 1.9+0.6
LoVo 320 50 6.9+ 2.6 0.5+0.6
100 6.8+ 3.5 0.3+0.2
250 3.7+ 0.9 0.3+0.3
500 3.4+ 1.7 ND
750 2.1+ 0.4 ND
Analysis was carried out following a 24h incubation of [1- 4C]-l-naphthol with
either COLO 206 cells (0.81 x 106 cells/ml) or LoVo cells (2.2 x 106 cellsml-1). Mean
values from 3-4 replicate cultures were used to determine the ID50 values for the
inhibition of protein synthesis. The metabolism data is presented as mean values
+s.d. for 3-4 replicate cultures. The data are from one experiment typical of 2
(COLO 206 cells) to 3 (LoVo cells).
ND=not detectable.
showed a three-fold increase in activity, whilst 1,4-
naphthoquinone was ten-fold more active (Figure
6b) (Cohen et al. 1983b). This difference in activity
may be due to the greater chemical reactivity of
1,2-naphthoquinone, which binds avidly to protein
(Rees & Pirie, 1967). When protein was removed
from the medium, by omitting foetal bovine serum
during the exposure period, both 1,2- and 1,4-
naphthoquinone showed similar inhibition of
protein synthesis (Table III). I-Naphthol was also
more toxic in the absence of serum, possibly due to
a greater availability.
Table III Effect of foetal bovine serum (FCS) on
1-naphthol and naphthoquinone inhibition of pro-
tein synthesis in LoVo cells.
ID50' (JMM)
Compound With FCS Without FCS
1-Naphthol 380 175
1,2-Naphthoquinone 140 22
1,4-Naphthoquinone 31 15
'ID50 is defined as the concentration required to
inhibit protein synthesis by 50%.
In a preliminary study with the short-term organ
culture system, the naphthoquinones were more
toxic than 1-naphthol and also retained some
degree of selective toxicity, to the tumour tissue
compared to the normal (Figure 6a). Some further
support for the involvement of naphthoquinone
formation in 1-naphthol toxicity was also suggested
from experiments using dicoumarol. In LoVo cells,
dicoumarol (10M) together with 1-naphthol (0.5
or 0.1 mM) produced a marked inhibition of
protein synthesis, which was not observed with
either agent alone. Dicoumarol was ineffective in
potentiating concentrations of 1-naphthol which
showed toxicity when acting alone (e.g. 0.25 and
0.5mM). In contrast to the LoVo cell line,
dicoumarol showed no potentiation of l-naphthol
toxicity in COLO 206 cells.
Discussion
The data presented in this study suggest a potential
use of 1-naphthol or related compounds in cancer
chemotherapy. Naphthols are not new to clinical
studies. In 1920, Smillie reported the successful
treatment of hookworm disease by administering 3
doses of 6g of 2-naphthol over 3 days. Four of the
79 patients in the study showed severe haemolytic
reactions, which in retrospect appeared to be due
to glucose-6-phosphate dehydrogenase deficiency
(Zinkham & Childs, 1958). However, the use of 1-
naphthol as an antitumour agent appears novel
although naphthoquinones have been studied ex-
tensively in the area. A major study of the potential
antitumour activity of a large number of
substituted naphthoquinones was carried out by the
National Institute of Health, a small number ofSELECTIVE TOXICITY OF I-NAPHTHOL 861
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Figure 6 Naphthoquinone toxicity to normal human
colon and tumour tissue and to colonic tumour cell
lines. Inhibition of protein synthesis in (a) short-term
organ cultures of human colonic tumour ( ), and
corresponding normal colon (----) by 1,4-
naphthoquinone in three different patients and (b)
LoVo cells by 1,4-naphthoquinone (-), 1,2-
naphthoquinone (0) and l-naphthol (0) was
determined. In both systems, the results are the mean
of 4 replicate cultures and 24h incubation with 1-
naphthol or the naphthoquinones.
which showed promise as chemotherapeutic agents
(Driscoll et al., 1974).
1-Naphthol was cytotoxic to colonic tumour cell
lines using several criteria (Figure 1) including protein
synthesis inhibition, clonogenic survival and trypan
blue uptake. These methods, in particular protein
synthesis inhibition, were chosen in order to compare
results in the cell lines with those from short-term
organ cultures of normal and tumour tissue.
Surprisingly, l-naphthol, and 1,4-naphthoquinone,
were not more toxic when assessed by clonogenic
survival compared to protein synthesis inhibition
(Figure la). We have compared the toxicity of
several known antitumour agents using these two
assays and as expected the clonogenic assay
appeared more sensitive, for example, ID50 values
of 3.0 and 0.3pgml-P for 5FU and adriamycin,
respectively, in LoVo cells estimated by protein
synthesis inhibition compared with values of 0.25
and 0.006pgml-P respectively using the clonogenic
assay. The reason is unclear but it is possible that a
major mechanism of toxicity of 1-naphthol may be
mediated by effects on cell membranes, which may
account for the cell lysis observed on exposure of
human colonic tumour cells to high concentrations
of l-naphthol.
It is the selectivity of l-naphthol against
colorectal tumours compared to normal colorectal
tissue that is the most important observation of this
study (Figure 2). There are several factors which
could be responsible for such selectivity. One
possibility, discussed earlier, was that of a selective
depletion of uridine nucleotides in the tumour
tissue resulting in inhibition of nucleic acid
biosynthesis. Several pieces of evidence did not
support this possibility. Firstly with COLO 206
cells maximal l-naphthyl-f-D-glucuronide forma-
tion was observed with 1-naphthol (100pM), a con-
centration which was only marginally toxic to the
cells (Figures lb and 5). If the mechanism of
toxicity had involved uridine nucleotide depletion,
then one would have expected increasing glucuronic
acid conjugate formation to reflect increasing
nucleotide depletion and increasing toxicity.
Secondly, the toxicity of l-naphthol to the human
colonic tumour cell lines COLO 206 and LoVo was
very similar although glucuronic acid conjugation
was 23-78 fold greater in the former (Table II).
Thirdly, at concentrations of 1-naphthol (1 mM),
which are selectively toxic to colonic tumour tissue
compared to normal tissue, normal human colonic
mucosa formed more l-naphthyl-f-D-glucuronide
than tumour tissue from the same patients (Figure
3). Whilst it would not appear that uridine
nucleotide depletion is involved in the toxicity of 1-
naphthol, it should be pointed out that differences
in the pool size of uridine nucleotides either
between the normal and tumour tissue or the
different cell lines might also explain the data.
A second possibility for the selective toxicity of
1-naphthol to the tumour compared to the normal
tissue was the impaired Phase II conjugative
metabolism in the tumour tissue (Table I and
Figure 3). This impaired metabolism resulted in a
marked progressive accumulation of l-naphthol in
tumour tissue compared to normal tissue (Figure
4b), which corresponded to an increase in selective
toxicity (Figure 4a). It could be argued that the
decreased metabolism of 1-naphthol (1 mM) in the
tumour tissue was due to its greater toxicity to the
tumour. However impaired conjugative metabolism
C 4-0
cJ 0
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of 1-naphthol was already evident at non-toxic
concentrations (20MM) (Table I and Gibby &
Cohen, 1984). The accumulation of 1-naphthol may
also have been due to selective uptake into the
tumour tissue. However a higher concentration of
metabolites was found in the medium from the
normal tissue (Figure 3) which must have arisen
following entry of 1-naphthol into the cells. As the
difference in nmoles of conjugate formed between
normal and tumour tissue was much greater than
the excess unmetabolised l-naphthol in the tumour
tissue, it is unlikely that the observed accumulation
of 1-naphthol in the tumour tissue was due to a
selective uptake.
The higher concentration of 1-naphthol in the
tumour tissue may exert its toxicity directly possibly
by interference with mitochondrial function
(Stockdale & Selwyn, 1971) or via metabolism
possibly to naphthoquinones. l-Naphthol, 1,2- and
1,4-naphthoquinone all caused a dose dependent
toxicity to hepatocytes which was potentiated by
dicoumarol (d'Arcy Doherty et al., 1984a).
Dicoumarol is an inhibitor of the flavoprotein
enzyme NAD (P) H: (quinone acceptor) oxidore-
ductase otherwise known as DT-diaphorase (Ernster,
1967). This enzyme catalyses the two electron
reduction of quinones to the hydroquinone without
the formation of cytotoxic semiquinone radical
intermediates and thus protects against quinone
toxicity produced by one electron reduction
mechanisms (Thor et al., 1982). Consequently,
blocking this enzyme with dicoumarol should present
greater amounts of quinone substrate to the cyto-
toxic pathways. Thus the potentiation of 1-naphthol
toxicity observed in hepatocytes in the presence of
dicoumarol is consistent with the formation of
naphthoquinones. Within a narrow concentration
range, dicoumarol potentiated the inhibition of
protein synthesis by l-naphthol in LoVo cells and
in approximately 50% of human biopsy specimens
so far tested but not in COLO cells, possibly due
to differences in DT-diaphorase in the different
cells. Whilst this limited data suggests a possible
involvement of naphthoquinones in the toxicity of
1-naphthol to tumour cells, more direct evidence is
required. In addition this data does not exclude
other mechanisms of toxicity.
In conclusion, this study has demonstrated the
selective toxicity of l-naphthol to human colorectal
tumours compared to normal colorectal tissue. The
selective toxicity may be mediated through an
accumulation of l-naphthol in the tumour tissue
due to impaired metabolism. The l-naphthol may
then mediate its toxicity either directly or by
formation ofcytotoxic naphthoquinones.
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